Late follow-up of occlusion of the patent ductus arteriosus with the Rashkind device with emphasis on long-term efficacy and risk for infections.
Formigari
R
R
Pediatric Cardiology, University of Bologna, Policlinico S. Orsola, Bologna, Italy. r.formigari@mclink.it
Toscano
A
A
Herraiz
I
I
Bialkowski
J
J
Donti
A
A
Picchio
F M
FM
Bermudez-Cañete
R
R
Ballerini
L
L
D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods; D006328:Cardiac Catheterization / Q000379:methods; D016001:Confidence Intervals; D004374:Ductus Arteriosus, Patent / Q000000981:diagnostic imaging / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011336:Probability; D016016:Proportional Hazards Models; D011475:Prosthesis Failure; D016459:Prosthesis-Related Infections / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D012189:Retrospective Studies; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler